How would you approach a patient with clinical T3N1 anorectal malignant melanoma referred by a surgeon for neoadjuvant therapy?
Is there a potential role for concurrent radiation therapy? What if the tumor is BRAF mutated?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · Mayo Clinic
Answered on
Anorectal malignant melanoma is quite rare and only <1 percent of all anorectal cancer are mucosal melanoma (Cagir et al., PMID 10496563)
Patients with newly diagnosed anorectal malignant melanoma should undergo HIV screening since HIV infection is considered to be one of the main risk factors (Cagi...
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · Renown Health Institute for Cancer
Answered on
Ok to tag on to this case, how about a deep pT4a cN0M0 BRAF WT low rectal mucosal melanoma s/p local excision with positive peripheral and deep margins, the only way to get R0 is with APR.
Would you recommend SC-RT (6 Gy x 5 fx) followed by ipi/nivo followed by APR?
Or APR followed by ipi/nivo (omit...
Join for free or sign in to see the full answer